BH

Bausch Health Companies Inc (BHC)

HealthcareDrug Manufacturers - Specialty & Generic
5.65USD
+1.06%
Magic Rank
#378
Earnings Yield
8.7%
Return on Capital
95.4%
Market Cap
2.1B

Performance vs S&P 500 (5Y)

BHC.US
S&P 500

About Bausch Health Companies Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Magic Formula Analysis

Enterprise Value21.7B
Market / Universe
us
USA

"A company with high ROC and high EY is statistically more likely to outperform the market."

Key Indicators

P/E RatioN/A
Dividend YieldN/A
Debt to Equity-35.38
Gross Margin25.8%